KLRK1 and neoplasm: Therefore, while our findings indicate that IL24-NKG2D-Exo can effectively target and induce apoptosis in tumor cells, it remains essential to evaluate their therapeutic potential in an in vivo system to confirm their efficacy, safety, and long-term stability.